RobertScottSvatekMD

Urology • San Antonio, TX

Professor and Chair, Urology, University of Texas Medical School, San Antonio

Join to view full profile

Dr. Svatek is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Svatek's full profile

Already have an account?

Office
8300 Floyd Curl Drive
4th Floor -4B
San Antonio, TX 78229
Phone+1 210-450-9600

Fax+1 210-450-9656

Education & Training

University of Texas Southwestern Medical CenterResidency, Urology, 2003 - 2007
University of Texas M D Anderson Cancer CenterInternship, Transitional Year, 2002 - 2003
University of Texas Medical Branch School of MedicineClass of 2002

Certifications & Licensure

TX State Medical License 2004 - 2025
American Board of Urology Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial Start of enrollment: 2011 Jul 01
Completed
Not Applicable
S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer Start of enrollment: 2011 Nov 25
Active, not recruiting
Not Applicable
A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer Start of enrollment: 2016 Jun 01
Completed
Early Phase 1
S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer Start of enrollment: 2017 Feb 24
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Se...
Roger Li, Patrick J Hensley, Shilpa Gupta, Hikmat Al-Ahmadie, Marko Babjuk
European Urology. 2024-12-01
Low-Dose Eribulin Promotes NK Cell-Mediated Therapeutic Efficacy in Bladder Cancer.
Zaineb Hassouneh, Onika D V Noel, Niannian Ji, Michelle E Kim, Jordan Svatek
Cancers. 2024-11-19
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomy.
Joep J de Jong, James A Proudfoot, Siamak Daneshmand, Robert S Svatek, Vikram Naryan
BJU International. 2024-11-01

Press Mentions

Modified Bladder Cancer Treatment Shows Promise in Animal StudiesAugust 23rd, 2022
Bladder Cancer Is More Aggressive and Advanced in South Texas, Study ShowsFebruary 25th, 2021
New Data Analyses from Phase 3 Study of Investigational Gene Therapy Nadofaragene Firadenovec Presented at Society of Urologic Oncology Annual Meeting Adds More Evidence to Data Published in Lancet OncologyDecember 2nd, 2020
Join now to see all